Company page

Lipigon Pharmaceuticals Ab

Lipigon Pharmaceuticals Ab (ticker: LPGO) is a public company based in Sweden, focusing on the development of innovative therapies for lipid-related diseases. The company is currently valued at a market capitalization of approximately 174 million SEK. Lipigon aims to address significant unmet medical needs in the field of lipid metabolism and related disorders.